Institut Pasteur, Unité Trafic Membranaire et Pathogenèse, 25-28 Rue du Docteur Roux, 75724, Paris CEDEX 15, France.
Institut Pasteur, Collection des Cyanobactéries, 25-28 Rue du Docteur Roux, 75724, Paris CEDEX 15, France.
Sci Rep. 2019 Apr 5;9(1):5741. doi: 10.1038/s41598-019-42161-6.
Tunneling nanotubes (TNTs) are actin-containing membrane protrusions that play an essential role in long-range intercellular communication. They are involved in development of various diseases by allowing transfer of pathogens or protein aggregates as well as organelles such as mitochondria. Increase in TNT formation has been linked to many pathological conditions. Here we show that nM concentrations of tolytoxin, a cyanobacterial macrolide that targets actin by inhibition of its polymerization, significantly decrease the number of TNT-connected cells, as well as transfer of mitochondria and α-synuclein fibrils in two different cell lines of neuronal (SH-SY5Y) and epithelial (SW13) origin. As the cytoskeleton of the tested cell remain preserved, this macrolide could serve as a valuable tool for future therapies against diseases propagated by TNTs.
隧道纳米管(TNTs)是一种含有肌动蛋白的膜突起,在细胞间的长距离通讯中发挥着重要作用。它们通过允许病原体或蛋白质聚集体以及细胞器(如线粒体)的转移,参与各种疾病的发展。TNT 形成的增加与许多病理状况有关。在这里,我们表明,纳摩尔浓度的托利毒素,一种通过抑制肌动蛋白聚合来靶向肌动蛋白的蓝细菌大环内酯,可显著减少 TNT 连接细胞的数量,以及两种不同的神经元(SH-SY5Y)和上皮(SW13)来源的细胞系中线粒体和α-突触核蛋白纤维的转移。由于测试细胞的细胞骨架仍然保持完整,这种大环内酯类药物可以作为未来针对 TNTs 传播疾病的治疗的有价值的工具。